The results showed that PDc possesses an improved synergistic effect towards HCC HepG2 cells in vitro and chick embryos assays in vivo, reducing the metastatic potential and secretion of pro-angiogenic factors through the multiple targeting of the Src/FAK pathway. The gene discussed is SRC; the disease is hepatocellular carcinoma.